In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at the start of the trial. However, the three drugs resulted in similar average improvement when starting vision was 20/40 to 20/32. Investigators found no major differences in the safety of the three drugs. The trial was funded by the National Eye Institute (NEI), part of the National Institutes of Health.

Related posts:

  1. MedicareCard.com Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina....
  2. Medicare Card, New NIH resources help growing number of Americans with vision loss Medicare Card, New NIH resources help growing number of Americans with vision loss...
  3. Medicare Card, Rehabilitation helps prevent depression from age-related vision loss Medicare Card, Rehabilitation helps prevent depression from age-related vision loss...
  4. NIH Encourages Americans to Make Vision a Priority NIH Encourages Americans to Make Vision a Priority ...
  5. MedicareCard.com, U.S. Latinos, Have High Rates of Developing Vision Loss, Certain Eye Conditions Latinos have higher rates of developing visual impairment, blindness, diabetic eye disease, and cataracts than non-Hispanic whites, researchers found. ...
  6. Avastin and Lucentis are equivalent in treating age-related macular degeneration At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of […]...
  7. Medicare, study uncovers new mechanism of action for class of chemotherapy drugs National Institutes of Health (NIH) researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors. They have also identified differences in the toxic capabilities of three drugs in this class which are currently being tested in clinical trials. The study, by […]...
  8. MedicareCard.com, National Eye Institute Shares Tips to Promote Eye Health During Healthy Vision Month 2010 During Healthy Vision Month this May, the National Eye Institute (NEI), part of the National Institutes of Health, is encouraging Americans to make vision health a priority and schedule an eye exam to help prevent unnecessary vision loss and blindness. Early detection and timely treatment can help save your sight and ensure that you’re seeing […]...
  9. Medicare Card, Targeting cholesterol buildup in eye may slow age-related vision loss Medicare Card, Targeting cholesterol buildup in eye may slow age-related vision loss...
  10. Medicare Card, Adults stop anti-rejection drugs after partial stem-cell transplant reverses sickle cell disease NIH trial success suggests a new treatment option for older, sicker patients.   Half of patients in a trial have safely stopped immunosuppressant medication following a modified blood stem-cell transplant for severe sickle cell disease, according to a study in the July 1 issue of the Journal of the American Medical Association External Web Site Policy. […]...
  11. Medicare Card, Drugs that activate brain stem cells may reverse multiple sclerosis Medicare Card, Drugs that activate brain stem cells may reverse multiple sclerosis...
  12. Medicare: Cholesterol levels elevated in toddlers taking anti-HIV drugs Toddlers receiving anti-HIV drugs have higher cholesterol levels, on average, than do their peers who do not have HIV, according to researchers at the National Institutes of Health and other institutions....
  13. Getting Your Eyes Checked – Mending Vision in Patients with Eye Vein Clots If the blockage is in a large vein, it's known as central retinal vein occlusion (CRVO). If it's in small branches of a vein, it's called branch retinal vein occlusion (BRVO). In some cases, the blockage can lead to fluid buildup in the center of the retina, or macular edema, a common cause of blindness....
  14. What is the difference between prescription drugs and over-the-counter drugs? What is the difference between prescription drugs and over-the-counter drugs...
  15. Healthy Vision Month May is Healthy Vision Month. You can help to protect your vision by getting comprehensive eye exams, which can detect glaucoma, diabetic eye disease, and other diseases that have no warning signs. Based on your eye health, family history, and age, your doctor can recommend how often you should get a comprehensive eye exam....